Shd Management, LLC

About

SHD Partners Skip to content Early-stage MedTech Investors Formed in 2006, Scientific Health Development (SHD) is a venture capital firm based in Dallas, TX. SHD invests in early-stage medtech companies based in the U.S. that address unmet clinical needs in healthcare. Optimal companies are focused on easily adoptable technologies aimed at improving patient outcomes while minimizing overall economic burden. History The genesis of Scientific Health Development (SHD) reaches back over 30 years. Philip Romano, a renowned restaurateur, was compelled to invest in a young, unproven radiology student with a big idea. Romano was the only outside investor in what became the Palmaz® stent, the world’s first coronary stent that created the multi-billion dollar stent market. Romano teamed up with Dallas businessman Stuart Fitts and, after years of successful angel investing, they formed a dedicated healthcare-focused investment firm in 2006 to continue their effective strategy via a dedicated and professional investment entity. This is the birth story of SHD. Subsequently, Andrew Offer was recruited in 2007 to supplement the firm’s financial acumen and research capabilities. Pulling from his background in healthcare valuation and reimbursement analysis, the firm has successfully invested multiple fund portfolios and has become a top early-stage medtech venture capital firm. The Firm Over the past 18 years, as SHD has grown its team and refined its investment thesis, we continue to stay t

Key Contact